FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to treatment of mesothelioma. Therapeutic agent for mesothelioma, which contains antibody to interleukin-6 (IL-6) receptor as its active ingredient, where mesothelioma is represented by pleural mesothelioma, where pleural mesothelioma is malignant pleural mesothelioma, where antibody to IL-6-receptor is represented by monoclonal antibody to IL-6-receptor, where antibody to IL-6-receptor is represented by monoclonal antibody to human IL-6-receptor, where antibody to IL-6-receptor is represented by antibody to murine IL-6-receptor, where antibody of IL-6-receptor is recombinant antibody, where monoclonal antibody to human IL-6-receptor is antibody PM-1, where monoclonal antibody to murine IL-6-receptor is antibody MR 16-1, where antibody to IL-6-receptor is chimeric antibody, humanised antibody or human antibody, where antibody to IL-6-receptor is chimeric antibody, humanised antibody or human antibody, where humanised antibody to IL-6-receptor is represented by humanised antibody PM-1, where humanised antibody to IL-6-receptor is represented by humanised antibody PM-1.
EFFECT: invention provides extension of arsenal for treating mesothelioma.
13 cl, 17 dwg, 14 ex
| Title | Year | Author | Number |
|---|---|---|---|
| THERAPEUTIC AGENT FOR MESOTHELIOMA | 2004 |
|
RU2392967C2 |
| PROPHYLACTIC DRUG FOR VASCULITIS | 2004 |
|
RU2379054C2 |
| METHOD OF TREATING INTERLEUKIN-6-DEPENDENT DISEASES | 2004 |
|
RU2509574C2 |
| AGENT FOR CARDIOPATHY | 2006 |
|
RU2450830C2 |
| THERAPEUTIC AGENT FOR TREATING DISEASES RELATED TO JUVENILE CHRONIC ARTHRITIS | 2002 |
|
RU2541165C2 |
| DRUGS AGAINST CHRONIC RHEUMATIC ARTHRITIS CONTAINING ANTAGONIST OF IL-6 AS EFFECTIVE COMPONENT | 1995 |
|
RU2147443C1 |
| THERAPEUTIC AGENT IN SPINAL MARROW INJURY CONTAINING INTERLEUKINE-6 ANTAGONIST | 2004 |
|
RU2358761C2 |
| AGENTS FOR SUPPRESSING TRANSPLANTED ISLAND DAMAGE FOLLOWING ISLAND TRANSPLANTATION | 2006 |
|
RU2446826C2 |
| THERAPEUTIC AGENT USED FOR GRAFT-VERSUS-HOST DISEASE, CONTAINING INTERLEUKIN-6 RECEPTOR INHIBITOR AS ACTIVE INGREDIENT | 2008 |
|
RU2490025C2 |
| THERAPEUTIC AGENT FOR DISEASES, RELATED TO CHILDREN'S CHRONIC ARTHRITIC DISEASES | 2002 |
|
RU2361613C2 |
